Literature DB >> 36033249

Haemolysis, elevated liver enzymes and low platelets: Diagnosis and management in critical care.

Evangelia Poimenidi1, Yavor Metodiev2, Natasha Nicole Archer3, Richard Jackson4, Mansoor Nawaz Bangash5, Phillip Alexander Howells6.   

Abstract

A thirty-year-old pregnant woman was admitted to hospital with headache and gastrointestinal discomfort. She developed peripheral oedema and had an emergency caesarean section following an episode of tonic-clonic seizures. Her delivery was further complicated by postpartum haemorrhage and she was admitted to the Intensive Care Unit (ICU) for further resuscitation and seizure control which required infusions of magnesium and multiple anticonvulsants. Despite haemodynamic optimisation she developed an acute kidney injury with evidence of liver damage, thrombocytopenia and haemolysis. Haemolysis, Elevated Liver enzymes and Low Platelets (HELLP) syndrome, a multisystem disease of advanced pregnancy which overlaps with pre-eclampsia, was diagnosed. HELLP syndrome is associated with a range of complications which may require critical care support, including placental abruption and foetal loss, acute kidney injury, microangiopathic haemolytic anaemia, acute liver failure and liver capsule rupture. Definitive treatment of HELLP is delivery of the fetus and in its most severe forms requires admission to the ICU for multiorgan support. Therapeutic strategies in ICU are mainly supportive and include blood pressure control, meticulous fluid balance and possibly escalation to renal replacement therapy, mechanical ventilation, neuroprotection, seizure control, and management of liver failure-related complications. Multidisciplinary input is essential for optimal treatment. © The Intensive Care Society 2021.

Entities:  

Keywords:  Haemolysis; elevated liver enzymes; hepatic; low platelets (HELLP); pre-eclampsia; pregnancy; seizures

Year:  2021        PMID: 36033249      PMCID: PMC9411774          DOI: 10.1177/17511437211025410

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  26 in total

Review 1.  Twelve steps to optimal management of HELLP syndrome.

Authors:  E F Magann; J N Martin
Journal:  Clin Obstet Gynecol       Date:  1999-09       Impact factor: 2.190

2.  Characteristics and treatment of hepatic rupture caused by HELLP syndrome.

Authors:  Ana C P F Araujo; Marcos D Leao; Maria H Nobrega; Patricia F M Bezerra; Flavio V M Pereira; Edailna M M Dantas; George D Azevedo; Selma M B Jeronimo
Journal:  Am J Obstet Gynecol       Date:  2006-03-30       Impact factor: 8.661

3.  Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center.

Authors:  Ygal Benhamou; Jean-Luc Baudel; Alain Wynckel; Lionel Galicier; Elie Azoulay; François Provôt; Frédéric Pène; Jean-Paul Mira; Claire Presne; Pascale Poullin; Jean-Michel Halimi; Etienne Rivière; Tarik Kanouni; Amélie Seguin; Christiane Mousson; Aude Servais; Dominique Bordessoule; Pierre Perez; Mohamed Hamidou; Dominique Chauveau; Agnès Veyradier; Paul Coppo
Journal:  Am J Hematol       Date:  2015-06       Impact factor: 10.047

Review 4.  HELLP Syndrome: Pathophysiology and Current Therapies.

Authors:  Kedra Wallace; Sharonda Harris; Augustina Addison; Cynthia Bean
Journal:  Curr Pharm Biotechnol       Date:  2018       Impact factor: 2.837

5.  Airway changes following labor and delivery in preeclamptic parturients: a prospective case control study.

Authors:  P Ahuja; D Jain; N Bhardwaj; K Jain; S Gainder; M Kang
Journal:  Int J Obstet Anesth       Date:  2017-11-06       Impact factor: 2.603

Review 6.  Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy.

Authors:  Douglas M Woudstra; Sue Chandra; G Justus Hofmeyr; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

Review 7.  Pregnancy and liver disease.

Authors:  Rachel H Westbrook; Geoffrey Dusheiko; Catherine Williamson
Journal:  J Hepatol       Date:  2015-11-30       Impact factor: 25.083

Review 8.  Disseminated intravascular coagulation in the HELLP syndrome: how much do we really know?

Authors:  Kjell Haram; Jan Helge Mortensen; Salvatore Andrea Mastrolia; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2016-06-08

Review 9.  Pre-eclampsia and cardiovascular disease.

Authors:  Christina W Chen; Iris Z Jaffe; S Ananth Karumanchi
Journal:  Cardiovasc Res       Date:  2014-02-13       Impact factor: 10.787

Review 10.  Comparing acute fatty liver of pregnancy from hemolysis, elevated liver enzymes, and low platelets syndrome.

Authors:  John J Byrne; Angela Seasely; David B Nelson; Donald D Mcintire; F Gary Cunningham
Journal:  J Matern Fetal Neonatal Med       Date:  2020-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.